Biology Reference
In-Depth Information
[108] Bennett CL, Fallah-Arani F, Conlan T, Trouillet C, Goold H, Chorro L, et al. Langerhans
cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin.
Blood 2011;117(26):7063-9.
[109] Sato K, Yamashita N, Baba M, Matsuyama T. Regulatory dendritic cells protect
mice from murine acute graft-versus-host disease and leukemia relapse. Immunity
2003;18(3):367-79.
[110] Teshima T, Reddy P, Lowler KP, KuKuruga MA, Liu C, Cooke KR, et al. Flt3 ligand
therapy for recipients of allogeneic bone marrow transplants expands host CD8 al-
pha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood
2002;99(5):1825-32.
[111] Blazar BR, McKenna HJ, Panoskaltsis-Mortari A, Taylor PA. Flt3 ligand (FL) treatment
of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment
of recipients post-bone marrow transplantation accelerates GVHD lethality. Biol Blood
Marrow Transplant 2001;7(4):197-207.
[112] Swee LK, Bosco N, Malissen B, Ceredig R, Rolink A. Expansion of peripheral naturally
occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood
2009;113(25):6277-87.
[113] Anderson BE, McNiff JM, Matte C, Athanasiadis I, Shlomchik WD, Shlomchik MJ. Re-
cipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
Blood 2004;104(5):1565-73.
[114] Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, et al. A crucial role for host
APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of
experimental graft-versus-host disease. J Immunol 2010;185(7):3866-72.
[115] Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, et al. Lan-
gerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that
induces the formation of Birbeck granules. Immunity 2000;12(1):71-81.
[116] Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH, et al.
Identification of a novel population of Langerin+ dendritic cells. J Exp Med
2007;204(13):3147-56.
[117] Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migra-
tion and maturation of Langerhans cells in skin transplants and explants. J Exp Med
1990;172(5):1483-93.
[118] Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, et al. Inducible
ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersen-
sitivity. J Cell Biol 2005;169(4):569-76.
[119] Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Lang-
erhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity
2005;23(6):611-20.
[120] Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG, et al.
Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol
2008;128(8):1950-5.
[121] Igyarto BZ, Jenison MC, Dudda JC, Roers A, Muller W, Koni PA, et al. Langerhans cells
suppress contact hypersensitivity responses via cognate CD4 interaction and Langer-
hans cell-derived IL-10. J Immunol 2009;183(8):5085-93.
[122] Igyarto BZ, Kaplan DH. The evolving function of Langerhans cells in adaptive skin im-
munity. Immunol Cell Biol 2010;88(4):361-5.
[123] Haley K, Igyarto BZ, Ortner D, Bobr A, Kashem S, Schenten D, et al. Langerhans cells
require MyD88-dependent signals for Candida albicans response but not for contact
hypersensitivity or migration. J Immunol 2012;188(9):4334-9.
[124] Nakajima S, Igyarto BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M, et al. Lang-
erhans cells are critical in epicutaneous sensitization with protein antigen via thymic
stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012;129(4):1048-
55; e6.
[125] Perreault C, Pelletier M, Belanger R, Boileau J, Bonny Y, David M, et al. Persistence of
host Langerhans cells following allogeneic bone marrow transplantation: possible
relationship with acute graft-versus-host disease. Br J Haematol 1985;60(2):253-60.
[126] Collin MP, Hart DN, Jackson GH, Cook G, Cavet J, Mackinnon S, et al. The fate of
human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med
2006;203(1):27-33.
[127] Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, et al. Langerhans
cells renew in the skin throughout life under steady-state conditions. Nat Immunol
2002;3(12):1135-41.
[128] Durakovic N, Bezak KB, Skarica M, Radojcic V, Fuchs EJ, Murphy GF, et al. Host-derived
Langerhans cells persist after MHC-matched allografting independent of donor T cells
and critically influence the alloresponses mediated by donor lymphocyte infusions.
J Immunol 2006;177(7):4414-25.
193
Search WWH ::
Custom Search